Regeneron Pharmaceuticals (REGN)
Net Receivables
$6.57B
Quarterly · Period ending: · USD
REGN Net Receivables
Latest reported$6.57Bperiod ending
Latest reported$6.57Bperiod ending
REGN Quarterly Net Receivables ($200.00K → $6.57B)
Quarterly net receivables
High-resolution chart · PNG
REGN net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 4,380,000 | |
| 8,608,000 | |
| 13,835,000 | |
| 9,851,000 | |
| 9,568,000 | |
| 8,560,000 | |
| 600,000 | |
| 8,600,000 | |
| 5,000,000 | |
| 7,000,000 | |
| 5,700,000 | |
| 5,400,000 | |
| 12,500,000 | |
| 4,600,000 | |
| 6,600,000 | |
| 4,100,000 | |
| 5,900,000 | |
| 3,300,000 | |
| 4,300,000 | |
| 6,000,000 | |
| 6,500,000 | |
| 4,300,000 | |
| 2,700,000 | |
| 4,500,000 | |
| 2,400,000 | |
| 2,400,000 | |
| 1,700,000 | |
| 1,600,000 | |
| 1,400,000 | |
| 1,500,000 | |
| 1,700,000 | |
| 1,700,000 | |
| 200,000 | |
| 1,100,000 | |
| 1,100,000 | |
| 1,600,000 | |
| 2,000,000 | |
| 1,600,000 | |
| 1,400,000 | |
| 1,900,000 | |
| 1,100,000 | |
| 200,000 |